Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization

BACKGROUND: The lastly identified claudin-low (CL) subtype of breast cancer (BC) remains poorly described as compared to the other molecular subtypes. We provide a comprehensive characterization of the largest series of CL samples reported so far. METHODS: From a data set of 5447 invasive BC profile...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabatier, Renaud, Finetti, Pascal, Guille, Arnaud, Adelaide, José, Chaffanet, Max, Viens, Patrice, Birnbaum, Daniel, Bertucci, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197217/
https://www.ncbi.nlm.nih.gov/pubmed/25277734
http://dx.doi.org/10.1186/1476-4598-13-228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197217/
https://www.ncbi.nlm.nih.gov/pubmed/25277734
http://dx.doi.org/10.1186/1476-4598-13-228

Ejemplares similares